Dysmenorrhea catastrophizing and functional impairment in female pelvic pain.

Autor: Li R; Center for Child Health, Behavior & Development, Seattle Children's Research Institute, Seattle, WA, United States., Kreher DA; Department of Psychiatry, University of Rochester School of Medicine & Dentistry, Rochester, NY, United States., Gubbels AL; Department of Obstetrics and Gynecology, Cleveland Clinic Foundation, Cleveland, OH, United States., Palermo TM; Center for Child Health, Behavior & Development, Seattle Children's Research Institute, Seattle, WA, United States.; Department of Anesthesiology & Pain Medicine, University of Washington School of Medicine, Seattle, WA, United States., Benjamin AR; Department of Obstetrics and Gynecology, University of Rochester School of Medicine & Dentistry, Rochester, NY, United States., Irvine CS; Department of Obstetrics and Gynecology, University of Rochester School of Medicine & Dentistry, Rochester, NY, United States., Hart A; Department of Obstetrics and Gynecology, University of Rochester School of Medicine & Dentistry, Rochester, NY, United States., Jusko TA; Department of Public Health Sciences, University of Rochester School of Medicine & Dentistry, Rochester, NY, United States., Seplaki CL; Department of Psychiatry, University of Rochester School of Medicine & Dentistry, Rochester, NY, United States.; Department of Public Health Sciences, University of Rochester School of Medicine & Dentistry, Rochester, NY, United States.
Jazyk: angličtina
Zdroj: Frontiers in pain research (Lausanne, Switzerland) [Front Pain Res (Lausanne)] 2023 Jan 06; Vol. 3, pp. 1053026. Date of Electronic Publication: 2023 Jan 06 (Print Publication: 2022).
DOI: 10.3389/fpain.2022.1053026
Abstrakt: Background: Dysmenorrhea is suggested to increase the risk of chronic pain by enhancing central sensitization. However, little is known about whether emotional and cognitive responses induced by dysmenorrhea contribute to chronic pain interference. This study examined the association between catastrophizing specific to dysmenorrhea and both dysmenorrhea and chronic pelvic pain (CPP)-associated pain interference.
Methods: Women ( N  = 104) receiving care for CPP through a tertiary gynecological pain clinic between 2017 and 2020 were recruited. They completed the Pain Catastrophizing Scale, the Brief Pain Inventory-pain interference, and a separate questionnaire regarding dysmenorrhea symptoms and treatment preceding the development of CPP. Dysmenorrhea catastrophizing and interference measures were developed and tested for internal consistency and construct validity. Multiple linear regression models examined dysmenorrhea catastrophizing in association with dysmenorrhea interference and CPP-associated pain interference.
Results: Dysmenorrhea catastrophizing and interference measures demonstrated excellent internal consistency (Cronbach's Alpha = 0.93 and 0.92 respectively) and evidence of construct validity (correlated with dysmenorrhea severity and treatment, Ps < 0.01). Dysmenorrhea catastrophizing was moderately correlated with pain catastrophizing ( ρ  = 0.30, P  = 0.003), and was associated with greater dysmenorrhea interference ( P  < 0.001) and CPP-associated pain interference ( P  = 0.032) accounting for general pain catastrophizing and other outcome-specific confounders. Dysmenorrhea intensity was most predictive of dysmenorrhea catastrophizing.
Conclusion: Among our clinical sample of women with CPP, dysmenorrhea catastrophizing was associated with greater dysmenorrhea interference and subsequent CPP-associated pain interference. More research is needed to determine whether reduction in dysmenorrhea catastrophizing leads to reduced pain interference associated with female pelvic pain.
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(© 2023 Li, Kreher, Gubbels, Palermo, Benjamin, Irvine, Hart, Jusko and Seplaki.)
Databáze: MEDLINE
Externí odkaz: